GMO Pepabo (3633) Fundamentals 2026 — P/E 11.1x, Revenue Analysis | SniperIQ
GMO Pepabo (3633) is a JP-listed Technology company in Software - Infrastructure with a market capitalization of ¥9.1B, trading at ¥1773.00 on the JPX. This SniperIQ fundamentals page covers GMO Pepabo's valuation (P/E 11.1x, P/B 3.8x), profitability (net margin 7.7%), revenue (¥11.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is GMO Pepabo's market cap?
GMO Pepabo (3633) has a market capitalization of approximately ¥9.1B, trading at ¥1773.00 on the JPX. Market cap moves with the live share price.
What is GMO Pepabo's P/E ratio?
GMO Pepabo's trailing twelve-month P/E ratio is 11.1x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
How profitable is GMO Pepabo?
GMO Pepabo runs a net profit margin of 7.7%, a gross margin of 53.9%, and an operating margin of 7.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does GMO Pepabo generate?
GMO Pepabo reported revenue of ¥11.0B for fiscal year 2025, with net income of ¥878M and earnings per share (EPS) of 168.68. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does GMO Pepabo pay a dividend?
GMO Pepabo offers a trailing dividend yield of about 6.3%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is GMO Pepabo financially healthy?
GMO Pepabo carries a debt-to-equity ratio of 0.16x and a current ratio of 1.13x, with a market beta of 0.66. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is GMO Pepabo a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For GMO Pepabo (3633) the key facts are: market cap ¥9.1B, P/E 11.1x, revenue ¥11.0B, 52-week range 1522-2675. Weigh valuation, profitability, growth, and balance-sheet strength against Technology peers and form your own view.
Track GMO Pepabo's full fundamentals live
Get GMO Pepabo's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.